Search results for: responding/{{ url('hprtheme:/scss/button.scss') }}

Guest: Dr. Aaron Glatt
Presenter: Neal Howard
Guest Bio: Dr. Aaron Glatt, MD, Chairman, Department of Medicine & Hospital Epidemiologist, South Nassau Communities Hospital

Segment overview: In this segment, Dr. Aaron Glatt, MD, Chairman, Department of Medicine & Hospital Epidemiologist, South Nassau Communities Hospital, discusses the findings from the South Nassau Truth In Medicine Poll that reflects an improper use of antibiotics and that attitudes differ based on gender, race, and age.

Overview:
• A study from Murdoch University, Neville Ellis interviewed 22 farmers from the Wheatbelt town in WA found that farmers’ mental health is being negatively impacted as weather patterns become more erratic and unpredictable.

• An inquiry into services for people with autism spectrum disorder is calling for submissions from the public, and Bendigo autism advocate Rebecca Kelly has outlined her concerns. Ms Kelly’s eight-year-old daughter was diagnosed with autism four years ago and her son, who is now six, was diagnosed a year later.

• The Garvan Institute of Medical Research warmly congratulates Professor Don Chisholm, who has been awarded a Doctor of Science (DSc) by UNSW Australia. This higher doctorate is accorded in recognition of a body of work that has made a significant contribution to a field of knowledge.

Dr. Craig Eagle, MD, Chief Medical Officer at Guardant Health discusses a new study published in “Nature Medicine” which demonstrated that using the Guardant360 liquid biopsy test can help guide treatment decisions for patients with HER2-driven metastatic colorectal cancer (mCRC). The Phase 2 study – TRastuzumab combIned with pertuzUMab for patients with Her2-positive mCRC (TRIUMPH) – showed that the Guardant360 test can select patients for HER2-directed therapy, identify which patients are responding to treatment, as well as identify genetic alterations that predict resistance.​ 

Guest: Professor Mark Hancock
Presenter: Wayne Bucklar
Guest Bio: Mark Hancock is an Associate Professor of Physiotherapy, Faculty of Medicine and Health Science, Macquarie University. He has 20 years of clinical experience as a musculoskeletal physiotherapist working in a primary care setting. Mark now works full time as an academic/researcher. His research focuses on the diagnosis and management of back pain. He has published over 70 peer reviewed papers and received over 2.7 million dollars in funding. He has published in leading medical journals (e.g. Lancet, BMJ and Annals of Internal Medicine) and discipline specific journals (e.g. Spine, Physical Therapy).

Segment overview: For our Health Academy Series today, our guest is Associate Professor of Physiotherapy Mark Hancock from the Faculty of Medicine and Health Science at the Macquarie University. He has a particular research interest in better understanding the causes of low back pain and identifying subgroups of patients who respond best to specific interventions. Today he will be sharing his thoughts about the different approaches which may lead to better outcomes. Many believe in better matching of treatment to individuals but how we do this is controversial and interesting.